Preferred Label : neisseria meningitidis, serogroup y;

MeSH definition : Strains of Neisseria meningitidis which, in the United States, causes disease in mostly adults and the elderly. Serogroup Y strains are associated with PNEUMONIA.;

MeSH synonym : meningococcus, serogroup y; meningococci, serogroup y;

MeSH annotation : infection: coord IM with MENINGITIS, MENINGOCOCCAL (IM) or, if not meningitis, MENINGOCOCCAL INFECTIONS (IM);

UNII : txid648194;

Details


Main resources

You can consult :

Strains of Neisseria meningitidis which, in the United States, causes disease in mostly adults and the elderly. Serogroup Y strains are associated with PNEUMONIA.

https://www.inspq.qc.ca/publications/3339
2023
Canada
public health guidelines
Serogroup
immunization programs
neisseria meningitidis, serogroup y
meningococcal infections
Vaccinia
meningococcus vaccination
Vaccins
neisseria meningitidis, serogroup C
vaccination
infectious disease, nos
preventive immunization/medication

---
http://www.has-sante.fr/portail/jcms/c_2041961/fr/nimenrix-vaccins-meningococciques-a-c-w135-et-y-conjugues
http://www.has-sante.fr/portail/jcms/c_2041961/fr/nimenrix
2015
false
France
French
tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine
tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine
guidelines for drug use
meningitis, meningococcal
antibiotic therapy
evaluation of the transparency committee
insurance, health, reimbursement
vaccination
injections, intramuscular
meningococcal infections
neisseria meningitidis, serogroup a
vaccines, conjugate
neisseria meningitidis, serogroup C
neisseria meningitidis, serogroup W-135
neisseria meningitidis, serogroup y
meningococcal vaccines
meningococcal vaccines
polysaccharides, bacterial
tetanus toxoid
meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
risk factors
infant
immunization schedule
immunization, secondary
drug interactions
child
adult
adolescent
treatment outcome
clinical trials, phase iii as topic
adaptive immunity

---
http://www.has-sante.fr/portail/jcms/c_1352587/nimenrix
http://www.has-sante.fr/portail/upload/docs/evamed/CT-12514_NIMENRIX_Insc_AVIS2_CT12514.pdf
2012
false
France
French
tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine
tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine
antibiotic therapy
evaluation of the transparency committee
insurance, health, reimbursement
vaccination
injections, intramuscular
meningococcal infections
neisseria meningitidis, serogroup a
vaccines, conjugate
neisseria meningitidis, serogroup C
neisseria meningitidis, serogroup W-135
neisseria meningitidis, serogroup y
meningococcal vaccines
meningococcal vaccines
polysaccharides, bacterial
tetanus toxoid
meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
risk factors
infant
immunization schedule
immunization, secondary
drug interactions
child
adult
adolescent
treatment outcome
clinical trials, phase iii as topic
adaptive immunity

---
https://ansm.sante.fr/uploads/2021/03/11/aa5aecf4fd671daf296a0a493b4a765b.pdf
2010
false
France
French
antibiotic therapy
vaccination
meningococcal infections
meningitis, meningococcal
meningococcal vaccines
vaccines, conjugate
polysaccharides, bacterial
neisseria meningitidis, serogroup W-135
neisseria meningitidis, serogroup y
child, preschool
neisseria meningitidis, serogroup a
neisseria meningitidis, serogroup C
child
risk factors
treatment outcome
meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
MenACWY-CRM vaccine
guidelines for drug use

---
Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.